Physician profile
Edward H Young
NPI 1356494595
$1,019.00
in general payments reported to CMS, 2019-2025
16 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $51.76 · 2021: $107 · 2022: $131 · 2023: $92.58 · 2024: $182 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $188.68 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $153.47 | 2019-2023 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $108.92 | 2025 | Assure Wcd |
| Abbvie INC. | $87.93 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $86.28 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $71.85 | 2019-2024 | Farxiga |
| Mylan Specialty L.P. | $57.55 | 2019-2024 | Yupelri |
| Pfizer INC. | $55.62 | 2019-2025 | |
| Novo Nordisk INC | $42.77 | 2024 | Ozempic, Rybelsus |
| Allergan, INC. | $35.35 | 2019 | |
| Chiesi USA, INC. | $31.63 | 2019 | |
| Abiomed | $26.67 | 2024 | Impella |
| Boston Scientific Corporation | $23.58 | 2025 | Watchman Access System |
| Vertex Pharmaceuticals Incorporated | $18.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.12 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14.58 | 2025 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.